ctrl K

Price Alert

Cognition Therapeutics In... (CGTX)

NASDAQ: CGTX · Real-Time Price · USD

1.75

0.08 (4.79%)

At close: Aug 20, 2025, 9:49 AM

Cognition Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	25.01M	29.92M	41.56M	54.72M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	1.73M	n/a
Receivables	2.69M	1.28M	3.67M	2.27M
Inventory	n/a	n/a	n/a	1.99M
Other Current Assets	n/a	n/a	n/a	-1.98M
Total Current Assets	29.55M	34.22M	47.65M	58.99M
Property-Plant & Equipment	679K	941K	1.05M	145K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	679K	941K	2.78M	145K
Total Assets	30.23M	35.16M	50.42M	59.14M
Account Payables	1.98M	3.69M	3.22M	4.17M
Deferred Revenue	1.07M	1.7M	1.7M	753K
Short-Term Debt	279K	544K	634K	n/a
Other Current Liabilities	1.53M	2.89M	870K	1.19M
Total Current Liabilities	11.14M	10.17M	7.79M	7.86M
Long-Term Debt	n/a	520K	n/a	n/a
Other Long-Term Liabilities	n/a	-520K	695K	n/a
Total Long-Term Liabilities	342K	520K	2.38M	4.17M
Total Liabilities	11.48M	10.69M	10.18M	7.86M
Total Debt	814K	1.24M	1.48M	n/a
Common Stock	60K	32K	29K	22K
Retained Earnings	-175.16M	-141.19M	-115.4M	-94M
Comprehensive Income	n/a	-195K	-199K	-198K
Shareholders Equity	18.75M	24.47M	40.25M	51.27M
Total Investments	n/a	n/a	n/a	n/a